These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 12239711)

  • 21. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients.
    Szuhai K; Jennes I; de Jong D; Bovée JV; Wiweger M; Wuyts W; Hogendoorn PC
    Hum Mutat; 2011 Feb; 32(2):E2036-49. PubMed ID: 21280143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.
    Cousminer DL; Arkader A; Voight BF; Pacifici M; Grant SFA
    Bone; 2016 Nov; 92():196-200. PubMed ID: 27616605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the anatomic burden of patients with hereditary multiple exostoses.
    Alvarez CM; De Vera MA; Heslip TR; Casey B
    Clin Orthop Relat Res; 2007 Sep; 462():73-9. PubMed ID: 17589361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel EXT1 and EXT2 mutations in hereditary multiple exostoses families of Indian origin.
    Vanita V; Sperling K; Sandhu HS; Sandhu PS; Singh JR
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):43-9. PubMed ID: 19309273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Denaturant gradient gel electrophoresis in the genetic diagnosis of hereditary multiple exostoses].
    He HB; Hu ZM; Li HJ; Zhu Y; Shi XL; Lei GH; Zhou JN; Li KH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):323-7. PubMed ID: 17478946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
    McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
    Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.
    Wuyts W; Van Hul W; De Boulle K; Hendrickx J; Bakker E; Vanhoenacker F; Mollica F; Lüdecke HJ; Sayli BS; Pazzaglia UE; Mortier G; Hamel B; Conrad EU; Matsushita M; Raskind WH; Willems PJ
    Am J Hum Genet; 1998 Feb; 62(2):346-54. PubMed ID: 9463333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.
    Mooij HL; Cabrales P; Bernelot Moens SJ; Xu D; Udayappan SD; Tsai AG; van der Sande MA; de Groot E; Intaglietta M; Kastelein JJ; Dallinga-Thie GM; Esko JD; Stroes ES; Nieuwdorp M
    J Am Heart Assoc; 2014 Dec; 3(6):e001274. PubMed ID: 25468659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation screening of EXT genes in Chinese patients with multiple osteochondromas.
    Kang Z; Peng F; Ling T
    Gene; 2012 Sep; 506(2):298-300. PubMed ID: 22820392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses.
    Dobson-Stone C; Cox RD; Lonie L; Southam L; Fraser M; Wise C; Bernier F; Hodgson S; Porter DE; Simpson AH; Monaco AP
    Eur J Hum Genet; 2000 Jan; 8(1):24-32. PubMed ID: 10713884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutations in the EXT1 gene in two consanguineous families affected with multiple hereditary exostoses (familial osteochondromatosis).
    Faiyaz-Ul-Haque M; Ahmad W; Zaidi SH; Hussain S; Haque S; Ahmad M; Cohn DH; Tsui LC
    Clin Genet; 2004 Aug; 66(2):144-51. PubMed ID: 15253765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.
    Stickens D; Clines G; Burbee D; Ramos P; Thomas S; Hogue D; Hecht JT; Lovett M; Evans GA
    Nat Genet; 1996 Sep; 14(1):25-32. PubMed ID: 8782816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses.
    Seki H; Kubota T; Ikegawa S; Haga N; Fujioka F; Ohzeki S; Wakui K; Yoshikawa H; Takaoka K; Fukushima Y
    Am J Med Genet; 2001 Feb; 99(1):59-62. PubMed ID: 11170095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutation analysis of EXT2 gene in a family with hereditary multiple exostosis].
    Li L; Li X; Liu Y; Zheng S; Zhang J; Liu Q; Heng X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):743-6. PubMed ID: 25449079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
    Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
    Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
    Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
    Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis of heparan sulfate in EXT1-deficient cells.
    Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
    Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A splicing mutation of EXT1 in a Chinese pedigree with hereditary multiple exostoses].
    Wang W; Qiu ZQ; Song HM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):174-80. PubMed ID: 24568913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
    Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
    Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.